(Q40265329)

19 September 2017

title

Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells (English)

1 reference

19 September 2017

1 reference

Huang Y

1

1 reference

19 September 2017

Li X

series ordinal

2

1 reference

19 September 2017

Jiang J

series ordinal

3

1 reference

19 September 2017

Frank SJ

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

19 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

25

1 reference

19 September 2017

issue

58

1 reference

19 September 2017

page(s)

7565-7576

1 reference

Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Cell-type specific phosphorylation of threonines T654 and T669 by PKD defines the signal capacity of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

The neu oncogene encodes an epidermal growth factor receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Structural design and molecular evolution of a cytokine receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin as an autocrine/paracrine growth factor in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Tyrosine kinase signalling in breast cancer: epidermal growth factor receptor and c-Src interactions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Regulation of signal transduction by endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

The role of prolactin in mammary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin receptor signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Tumor-promoting phorbol diesters cause the phosphorylation of epidermal growth factor receptors in normal human fibroblasts at threonine-654

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Endocytosis and signaling. an inseparable partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

A synthetic inhibitor of the mitogen-activated protein kinase cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Transactivation of erbB2 by short and long isoforms of leptin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin inhibits epidermal growth factor (EGF)-stimulated signaling events in mouse mammary epithelial cells by altering EGF receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Regions of the JAK2 tyrosine kinase required for coupling to the growth hormone receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Epidermal growth factor protects epithelial cells against Fas-induced apoptosis. Requirement for Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Development and potential clinical uses of human prolactin receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin: the new biology of an old hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Should prolactin be reconsidered as a therapeutic target in human breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin and estrogen enhance the activity of activating protein 1 in breast cancer cells: role of extracellularly regulated kinase 1/2-mediated signals to c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Plasma Prolactin Levels and Subsequent Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin, epidermal growth factor or transforming growth factor-alpha activate a mammary cell-specific enhancer in mouse mammary tumor virus-long terminal repeat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Epidermal growth factor receptor inhibition strategies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

The ErbB receptors and their role in cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin and mammary gland development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Physical and functional interaction of growth hormone and insulin-like growth factor-I signaling elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Growth hormone-dependent tyrosine phosphorylation of a GH receptor-associated high molecular WEIGHT protein immunologically related to JAK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Growth hormone-induced alteration in ErbB-2 phosphorylation status in 3T3-F442A fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Involvement of the Src homology 2-containing tyrosine phosphatase SHP-2 in growth hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

A role for Grb2-associated binder-1 in growth hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Epidermal growth factor receptor: a promising target in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Estrogen/EGF receptor interactions in breast cancer: rationale for new therapeutic combination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Expression Cloning of Human EGF Receptor Complementary DNA: Gene Amplification and Three Related Messenger RNA Products in A431 Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Stat5a is mandatory for adult mammary gland development and lactogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Involvement of prolactin in breast cancer: redefining the molecular targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

EGFR and cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Heregulin induces tyrosine phosphorylation of HER4/p180erbB4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin decreases epidermal growth factor receptor kinase activity via a phosphorylation-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Signaling by the Drosophila epidermal growth factor receptor pathway during development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Prolactin involvement in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Growth hormone attenuation of epidermal growth factor-induced mitogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Trafficking of the ErbB receptors and its influence on signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Computational modeling of the EGF-receptor system: a paradigm for systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Protein kinase C phosphorylation of the EGF receptor at a threonine residue close to the cytoplasmic face of the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

Elasticity of technique: the psychoanalytic project and the trajectory of Ferenczi's life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Threonine phosphorylation diverts internalized epidermal growth factor receptors from a degradative pathway to the recycling endosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: results of a double blind multicentre clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Prolactin inhibits EGF-induced DNA synthesis in mammary epithelium via early signaling mechanisms: possible involvement of protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Prolactin: structure, function, and regulation of secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Prolactin as a Chemoattractant for Human Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Expression of prolactin and its receptor in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

PRL modulates cell cycle regulators in mammary tumor epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Thapsigargin, a novel promoter, phosphorylates the epidermal growth factor receptor at threonine 669

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Growth hormone-induced tyrosine phosphorylation of EGF receptor as an essential element leading to MAP kinase activation and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209740

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209740

1 reference

Dimensions Publication ID

19 September 2017

1033698878

0 references

1 reference